Inventor
GUO JUNQING
US23 patents
⚠️ This page may combine multiple inventors who share the name “GUO JUNQING”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BRISTOL MYERS SQUIBB CO
14 patentsUS7105667B2Sep 12, 2006
Fused heterocyclic compounds and use thereof
BRISTOL MYERS SQUIBB CO25 citations92
US7087614B2Aug 8, 2006
Pyrimidine inhibitors of phosphodiesterase (PDE) 7
BRISTOL MYERS SQUIBB CO35 citations89
US10913738B2Feb 9, 2021
Aminotriazolopyridines as kinase inhibitors
BRISTOL MYERS SQUIBB CO7 citations83
US11767322B2Sep 26, 2023
Triazolopyridinyl compounds as kinase inhibitors
BRISTOL MYERS SQUIBB CO3 citations70
US12157733B2Dec 3, 2024
Aminotriazolopyridines as kinase inhibitors
BRISTOL MYERS SQUIBB CO0 citations62
US7737279B2Jun 15, 2010
1,6-dihydro-1,3,5,6-tetraaza-as-indacene based tricyclic compounds and pharmaceutical compositions comprising same
BRISTOL MYERS SQUIBB CO4 citations62
US12110290B2Oct 8, 2024
Triazolopyridinyl compounds as kinase inhibitors
BRISTOL MYERS SQUIBB CO0 citations61
US12275721B2Apr 15, 2025
Indazole carboxamides as kinase inhibitors
BRISTOL MYERS SQUIBB CO0 citations52
US12172975B2Dec 24, 2024
1H-indazole carboxamides as receptor-interacting protein kinase 1 inhibitors (RIPK1)
BRISTOL MYERS SQUIBB CO0 citations52
US12084426B2Sep 10, 2024
Indazole carboxamides as kinase inhibitors
BRISTOL MYERS SQUIBB CO0 citations51
US11618753B2Apr 4, 2023
Aminopyrrolotriazines as kinase inhibitors
BRISTOL MYERS SQUIBB CO0 citations51
US7981881B2Jul 19, 2011
Fused heterocyclic compounds and use thereof
BRISTOL MYERS SQUIBB CO0 citations51
US7384937B2Jun 10, 2008
Fused heterocyclic compounds and use thereof
BRISTOL MYERS SQUIBB CO0 citations51
US10301306B2May 28, 2019
Substituted dihydro-1H-pyrrolo[3,2-c]pyridin-4(5H)-ones as RIPK3 inhibitors
BRISTOL MYERS SQUIBB CO0 citations40
FURUKAWA CO LTD
3 patentsUS10468573B2Nov 5, 2019
Thermoelectric conversion material
FURUKAWA CO LTD1 citations59
US10056536B2Aug 21, 2018
Thermoelectric conversion material, thermoelectric conversion element, thermoelectric conversion module, thermoelectric generator, thermoelectric conversion system, and method of manufacturing thermoelectric conversion material
FURUKAWA CO LTD1 citations48
US10790431B2Sep 29, 2020
Method of manufacturing thermoelectric conversion material
FURUKAWA CO LTD0 citations37
WROBLESKI STEPHEN T
3 patentsUS8987268B2Mar 24, 2015
Pyrrolopyridazine JAK3 inhibitors and their use for the treatment of inflammatory and autoimmune diseases
WROBLESKI STEPHEN T2 citations50
US9221826B2Dec 29, 2015
Pyrrolopyridazine JAK3 inhibitors and their use for the treatment of inflammatory and autoimmune diseases
WROBLESKI STEPHEN T1 citations49
US8921368B2Dec 30, 2014
Pyrrolopyridazine JAK3 inhibitors and their use for the treatment of inflammatory and autoimmune diseases
WROBLESKI STEPHEN T0 citations39